Ezintsha study provides new data on current ART regimens with concerns about weight gain

(University of the Witwatersrand) The South African study ADVANCE by Ezintsha, a research group at the University of the Witwatersrand, which focuses on investigating better options for first-line antiretroviral treatment for people with HIV, today published its 96-week outcomes, providing new safety data, especially on weight gain.